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Summary.-Patients with acute lymphatic leukaemia (ALL) could be divided into
two groups at diagnosis-those whose peripheral blood and/or bone marrowexhibited
in vitro colony formation and those in whom it did not, but this finding did not appear
to correlate with any clinical or haematological parameter, or with prognosis. The
colony-forming potential of patients with ALL in their first full remission, early
relapse or second remission did not deviate significantly from previously established
normal values, but the colony-forming potential of patients in early remission was
very significantly reduced. No loss of colony-forming potential of normal marrow
cells was noted when they were cultured with cells from patients with ALL.
WHILE acute leukaemia in children is
usually a disease of lymphatic origin, its
nature is such that granulopoiesis is
frequently compromised. Since the re-
covery and maintenance of granulocyte
number and function is central to the
achievement and maintenance of remis-
sion, the study of granulocyte precursors
is relevant in ALL. One method for the
assessment ofgranulocytic potential is the
in vitro agar colony-forming cell (CFC)
assay, in which colonies of granulocytes
and macrophages may be grown from their
common precursor cell (the CFC).
We have studied a total of 43 patients
at various stages of their illness, bone
marrow samples being taken only when
these were indicated under the appropriate
treatment protocol or as part ofthe general
management of the patient. We have
attempted to answer two basic questions:
(1) Certain prognostic factors are
recognized in ALL, such as age,
peripheral blood leucocyte count
and mediastinal involvement, but
they give only a crude guide to
prognosis. Could the assessment
of colony-forming potential or
other features of colony growth
help to distinguish patients with
good or poor prognosis?
(2) What variations may be detected
by the in vitro CFC assay during
the various stages of the disease?
MATERIALS AND METHODS
Patients with leukaemia. Forty-three
patients with acute lymphatic leukaemia were
studied. Diagnosis was based on clinical and
morphological grounds and, with the excep-
tion of 4 adults, all were accepted into the
MRC CONCORD or UKALL trials (Medical
Research Council Working Party, 1973) and
treated according to the allocated protocol.
The criteria for the diagnosis ofremission and
relapse were in accordance with the appro-
priate trial.
Collection of samples-Samples of iliac
crest marrow were aspirated under ketamine
anaesthesia (local anaesthesia in older
patients) and placed in bottles containing 5 ml
collecting medium (BHK Eagle's from Well-
come Reagents Ltd) supplemented with 10%
foetal calfserum (Flow Laboratories Ltd) and
10% trypticase soy broth (Difco), with 100GRANULOPOIESIS IN ACUTE LYMPHATIC LEUKAEMIA
i.u. preservative-free heparin (Weddel Phar-
maceuticals Ltd, London). Excess erythro-
cytes wNere removed by layering these samples
over methyl-cellulose/triosil (Hullinger and
Blaztiovec, 1967) and allowing them to
sediment at room temperature for 30-50 min.
The leucocyte-rich upper layer was collected,
the leucocytes washed once, resuspended in
collecting medium and a nucleated-cell count
performed.
Peripheral blood samples fromthepatients
were collected in preservative-free heparin
and leucocyte suspensions prepared by allow-
ing the blood to sediment and removing the
leucocyte-rich supernatant plasma, the cells
were concentrated by centrifugation, washed
twice and resuspended in collecting medium
and a nucleated-cell count performed prior to
culture.
Culture technique.-All cultures were per-
formed by the double-layer technique in
Nunclon 30-mm plastic dishes (A/S Nunc,
Denmark) using the modified Eagle's medium
previously described (McNeill, 1971). CS
factor w%Nas provided by the inclusion of 5%0
(v/v) of human spleen or human embryo cell-
conditioned medium (Bradley and Sumner,
1968) in the Eagle's 1200 agar underlayer,
this being the optimum concentration for
colony growth of normal human marrow, as
determined by previous titration. Eagle's
0.3%o agar medium was held at 37TC, cells
added to the concentration required and 1-ml
aliquots placed upon the gelled underlayers.
All cell suspensions were cultured in quad-
ruplicate. Cultures were incubated for 7 days
at 37°C in sealed boxes containing 10% CO2
in humidified air, and colonies (aggregates of
> 20 cells) counted with a stereoscopic
microscope at x 40 magnification; the
figures shown for colony counts are the mean
of the 4 replicate cultures.
Co-culhire procedure
Normal bone marrow cells for co-culture
were obtained from segments of rib removed
at thoracotomy from patients in whom no
haematological abnormality was present.
The rib segments were placed in collecting
medium and the cells suspended in this
medium by washing through the medullary
eavity with a Sahli marrow aspiration needle
attached to a syringe.
The normal and leukaemic samples for
co-culture were cultured separately at cell
concentrations of 1, 2, 3 and 4 x 105 cells per
ml respectively. Co-cultures were performed
so that the total number of cells per ml was
kept constant at 5 x 105 providing cultures
with ratios of 1 : 4, 2 :3, 3 :2 and 4 :1 of
the two cell populations being co-cultured.
Where insufficient cells were available, all cell
concentrations were halved, giving a total
cell concentration of 2-5 x 105 per ml.
Plan of study
Samples were obtained from patients at
6 distinct phases of their illness. These were:
(i) At diagnosis.
(ii) During early remission, i.e., leukaemic
cells absent from peripheral blood
and bone marrow, and before the
start of prophylactic CNS irradiation
(usually Week 4-6).
(iii) During full remission, i.e., once
cyclical maintenance therapy com-
menced. As many as 12 samples
were obtained from some of the
patients with prolonged remissions.
In order to prevent statistical bias
from the inclusion of a large number
of results from one or two patients,
the samples were arranged in sub-
groups for analysis, each subgroup
containing only one sample from each
patient. When a second sample had
been cultured, this was entered into
the second subgroup, and so on to the
12th subgroup. As samples from
patients in remission were normally
taken at 12-weekly intervals, the
latter subgroups clearly contain the
patients with prolonged remissions.
(iv) During the course of prophylactic
CNS irradiation.
(v) Early relapse. These were patients
in their first remission in whom bone
marrow aspiration revealed an in-
crease in blast cells.
(vi) Patients in second remission.
Statistical methods
Tests of normality (Snedecor and Coch-
ran, 1968) showed that the square roots ofthe
colony counts were alwaIys normally dis-
tributed, although the untransformed data
were not always so. The square roots of the
colony counts were therefore used for com-
parison ofthe mean colony counts (and t tests)
and for tests of correlation. These were
performed on an Olivetti Program 101
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Computer. Chi-squared tests for the com-
parison of two proportions were not applic-
able in some instances, because of small
numbers in one portion ofthe table. Fisher's
exact probability tests were therefore used
and these were performed with an ICL 1907
computer.
RESULTS
Colony growth at diagnosis
Peripheral blood and/or bone marrow
samples were obtained from 20 patients at
diagnosis. Two distinct groups were
found-8 patients whose cells grew colo-
nies and 12 whose cells did not. These
results, together with clinical and haema-
tological data, are given in Tables IA and
IB.
Patien
Patient
W.G.B.
H.D.
M.McC.
T.McA.
J.McB.
F.D.
P.M.
M.B.
No difference between the two groups
was found in terms of age, sex, peripheral
blood leucocyte or blast-cell count. The
degreeofmarrowreplacementbyleukaemic
cells was similar, as was the degree of
splenic and lymph-node involvement.
Prognosis was also unaffected, since:
(a) all patients came into remission
(except one who died from a
cerebral haemorrhage) and
(b) median survival was similar in
both groups (approximately 2
years) withbothgroupscontaining
some long survivors.
It is ofinterest that those patients who
possessed colony-forming ability had signi-
TABLE IA.-Clinical and Haematological Data ofPatients whose
Blood or Bone Marrow Grow Colonies at Diagnosis
Colonies per culture
It data Peripheral blood Degree of of cell concentration
k ) leucocyte count % Blast bone marrow Sample , A
Sex Age (units) cells replacement cultured 1 x 106 5 x 105 2.5 x 105 1 x 105
M 4 6*0 83 C* P.B.t 54±6 31±2 17±4 9±3
B.M. 7±1 2±1 1±1 0
F 5 5*5 67 C P.B. 44±1 20±2 - 2±1
B.M. 12±2 8±2 - 0
M 2 154-0 96 C P.B. 3±2 0 0 0
B.M. 33±4 - 0 0
M 19 5-8 22 C P.B. 19±3 15±2 8±2 3±1
M 44 6*3 49 C P.B. 39±4 - 5±1
M 45 11*4 68 C P.B. 36±1 10±1 3±2 1±1
M 5 1- 7 7 30% B.M. 87±11 41±3 -
F 6 7 0 57 C B.M. 3±1 1±1 - 1±1
* C = Virtually complete replacement of marrow by leukaemic cells.
t P.B. = peripheral blood: B.M.; bone marrow.
TABLE 1B.-Clinical and Haematological Data ofPatients whose Blood and
Bone Marrow did not Grow Colonies at Diagnosis
Peripheral blood
leucocyte count
(units)
100*7
26 3
73-5
13 6
17-7
512-0
4-7
27-6
1-*8
0*4
3 9
55-2
2*7
Degree of
% Blast bone marrow
cells replacement
94 C*
83 C
80 C
68 80%
80 C
90
52 C
80 C
70 C
4 C
33 70%
85 C
48 C
* C = Virtually complete replacement of marrow by leukaemic cells.
Patient data
I
Patient
C.R.
D.B.
C.McD.
M.McA.
Y.E.
M.P.
L.K.
S.P.
J.McC.
L.McG.
D.McD.
G.M.
Sex
M
M
M
F
F
M
F
F
M
M
F
M
Age
12
12
5
8
33
3
3
6
17
8
4
5
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ficantly fewer colony-forming cells in
marrow and significantly more in peri-
pheral blood, than normal individuals
(Morris, McNeill and Bridges, 1974). In
other respects, such as the relationship of
colony number to concentration of cells
cultured and the requirement for extra-
neous CS factor, the cultures behaved
very similarly to those from normal
individuals.
Co-culture with normal marrow
Co-culture of peripheral blood and/or
bone marrow cells from 9 ofthese patients
was performed. Table IIA shows the
results for 5 patients in whom no colony
formation was found. The colony-forming
potential of the normal rib marrow cul-
tured alone may be compared with that
when co-cultured with the leukaemic cells.
In 3 ofthe patients no inhibition is seen at
any ratio, while that seen in M.P. and
L.K. is no greater than that observed
when normal peripheral blood is co-
cultured with normal rib marrow (Morris,
McNeill and Bridges, 1975).
TABLE IIA.-The Effect of Co-culturing Rib Marrow Cells and Cells from Patients with
Acute Lymphatic Leukaemia Showing no Growth of Colonies
Colonies per culture
4x 105 Rib 3 x 105 Rib 2 X 105 Rib 1 x 105 Rib
marrow cells marrow cells marrow cells marrow cells
+1x 105 +2X 105 +3X 105 +4X 105 A1one Cells Alone cells Alone cells Alone cells
C.McD. B.M. 310 336 295 300 275 238 170 155
P.B. 310 335 295 273 275 240 170 160
C.R. B.M. 135 115 106 97 89 79 55 58
P.B. 135 127 106 103 89 70 55 46
M.P. B.M. 155 133 121 91 105 69 60 44
L.K. B.M. 196 170 162 111 128 79 96 40
Y.E. P.B. 259 258 220 229 185 190 105 94
TABLE IIB.-The Effect of Co-culturing Rib Marrow Cells (N) and Cells from Patients
with Acute Lymphatic Leukaemia Showing Colony Formation (L)
Colonies per culture
, K .~~~~~~~~~~~~~ Separate
cultures
N=4x 105 Co-culture
Patient SampeL=e1X105 5x105
W.G.B. B.M. 118
0 (118) 114
P.B. 118
9 (127) 141
M.B. B.M. 164
0 (164) 173
P.B. 164
0 (164) 179
H.D. B.M. 121
0 (121) 119
P.B. 121
2 (123) 115
T.McA. P.B. 119
3 (122) 87
59
Separate Separate Separate
cultures cultures cultures
N=3 x 105 Co-culture N=2 x 105 Co-culture N=I x 105 Co-culture
L= 2x105 5x105 L=3x105 5X105 L=4x105 5x105
97 73 60
0 (97) 82 1 (74) 52 2 (62) 42
97
16 (113) 116
141
0 (141) 137
141
0 (141) 127
111
1 (112) 105
111
7 (118) 103
105
6 (111) 102
73
23 (96) 110
120
0 (120): 131
120
0 (120) 117
84
1 (85) 82
84
12 (96) 77
77
9 (86) 46
60
(85) 61
25
81
1 (82) 68
81
0 (81) 87
56
4 (60) 51
56
16 (72) 54
40
11 (51) 25
871872 ~~~~~~T. C. M. MORRIS ET AL.
TABLE III.-Comparison.of the Colony-forming Potential of Marrow Samples from
Patients with Acute Leukaemia in Early Remission and Normal Rib Marrow
Cell concentration
per culture
Normal rib marrow
n
mean
s.d.
s.e.
ALL early remission
marrow
n
mean
s.d.
s.e.
Difference
s.e. difference
P
106
90
12-7
4*04
0-43
23
5.9
2 -97
0-62
6-8
0-75
0-001
2*5x 105
(181-0)
(99.-1)
(10.-4)
(44-0)
(37-0)
(7.-7)
(137.-0)
(12.-95)
75
8-5
2-92
0-34
19
4-1
2-64
0-61
4.4
0-70
0.001
105
(79-0)
(46.-2)
(5.3)
(24-0)
(26.-6)
(6.-10)
(55-0)
(8-11)
74
5-8
2 -22
0-27
19
2-2
2 -09
0-48
3-6
0-55
0.001
(39-0)
(26.9)
(3.-1)
(9.-0)
(15.-5)
(3.-5)
(30-0)
(4-65)
The comparison was carried out using the square root of the individual colony counts.
The figures in parentheses are for untransformed data.
Table JIB shows the results of co-
culture of normal rib marrow and 4 of the
patients from the group showing colony
growth. The counts of separate cultures
at each cell concentration are shown and
the sum of these counts are shown in
brackets for comparison with the figure
obtained by co-culture; the results show
no significant inhibition.
Colony growth in remission and relapse
(a) Early remission.-Marrow samples
were obtained from 23 patients, usually
during the fourth week of treatment, and
admitted to this group ifthe proportion of
blast cells was < 5%. The mean colony
count of the group was compared to that
of normal marrow samples previously
described (Morris et al., 1974) and it can
be seen in Table III that the mean colony
count of the patients in early remission
was significantly lower than that ofnormal
marrow (P < 0-001 at all cell concentra-
tions tested).
(b) Full remission.-A total of 115
samples were obtained from 35 patients
who were in full remission, 12 samples
being obtained from 2 patients each of
whom had remissions in excess of 3 years.
The Fig. shows the colony counts obtained
from these samples when cultured at
0 0
8
0 0
0
0 0 0 c 0
0
0
0 0 0
-
0 0
0 0 0
0 8 0 0
0
0 0
0
0
0
00 0
0
0
0
4
j 8 0
0 0
00 0 0
2 3 4 5 6 7 8 9 10 12
S.Wl. N..b.,
FiG.-Colony-forming potential of marrow
c3lls cultured at 2-5 x 105 cells/culture from
patients in full remission. Each circle in
the first vertical column represents the
mean count of the first sample taken from
a patient when in full remission; each
subsequent sample beinga given in the appro-
priate column. Horizon~tal broken lines
represent ±s.d. from the mean for colony
counts from 90 normal marrow samples.
2-5 X 105 cells per culture. The mean
value ± s.d. for 90 normal rib marrow
samples is shown between the broken
horizontal lines. Similar relationships
were obtained with culture at 105 and
106 cells per culture. The colony counts
were not found to vary with the patient's
872
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sex, age or length of time from diagnosis
to sampling, nor did the counts ofpatients
who survived for longer than 3 years
differ from those who died within one
year. No significant differences were
found between the mean counts of
patients not receiving treatment with any
particular agent, either singularly or in
combination.
(c) Colony-forming potential at other
times.-Bone marrow samples from 14
patients receiving CNS irradiation, 15
patients in early haematological relapse
after first remission and 6 patients in
second remission were assayed for colony
formation at 106, 2-5 X 105 and 105 cells
per culture. When compared with normal
marrow, the counts ofthe CNS irradiation
group were lower at 106 cells per culture
(0.05 > P > 0.025, Student's t test using
transformed data) but not at the other cell
concentrations. The counts of patients in
second remission did not differ from those
of normal marrow, nor did those of
patients in early relapse.
DISCUSSION
The growth of myeloid colonies from
bone marrow and peripheral blood ofsome
patients with ALL confirms the findings
of other workers (Mack, Robinson and
Holton, 1972; Moore et al., 1974; Ragab,
Gilkerson and Myers, 1974). We were
unable to distinguish between patients
who showed colony growth and those who
did not on any other clinical or haema-
tological grounds, and this feature did not
haveanynoticeableprognosticsignificance
While there are many reports of
normal or raised colony formation in
patients with acute leukaemia in remis-
sion, there are few serial follow-up studies.
Ragab et al. (1974) cultured 129 marrow
samples from a total of 62 children with
ALL in complete remission over a 9-
month period, and found they had a signi-
ficantly lower colony-forming potential
than 17 controls, but were still signi-
ficantly higher than patients at diagnosis
or relapse. Although their data were
compared by the Wilcoxon rank sum test,
it did not make allowances for replicate
samples affecting the analysis. The re-
duction in colony-forming potential which
they show for all patients in remissionmay
be due to the fact that they have not
segregated results from patients in early
remission, particularly as marrow aspira-
tions were performed every 4 weeks
initially. However they did note in 3 out
of 7 marrows taken one week after com-
mencing therapy, when the blast cell
count had fallen to < 5%, that there was
no rise in colony-forming potential. In
the present study, marrow samples taken
at 4-6 weeks after the initiation oftherapy,
at which time there was good recovery of
normal cellularity, the colony-forming
potential was still significantly reduced.
It is generally accepted that the CFC is
is the committed granulopoietic/macro-
phage stem cell, and it would seemreason-
able to expect a marked increase in such
cells as the leukaemic cell population is
destroyed and replaced with normal hae-
mopoietic tissue. Yet CFC numbers
remain low until remission is well estab-
lished. A number of explanations are
possible:
(a) CFC are present in the marrow of
leukaemic patients, but are sup-
pressed by the leukaemic cells.
However, this does not seem
likely, as CFC numbers do not
return to normal until long after
all recognizable leukaemic cells
have disappeared from the blood
and bone marrow. In addition,
our co-culture experiments with
normal marrow and ALL cells
failed to show the marked in vitro
inhibition seen when normal
marrow was co-cultured with cells
from patients with AMML (Morris
et al., 1975).
(b) A delay in maturation from pluri-
potential stem cells also seems
improbable, since the peripheral
blood granulocyte count and the
number ofmorphologically identi-
fiable granulocyte precursors in
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bone marrow return to normal
more rapidly than the number of
CFC.
(c) The effect is most likely due to a
rapid transit of cells through the
phase of differentiation associated
with colony-forming ability. In
experimental systems, it has been
shown thatinregenerating marrow
the proportion ofCFC to stem cells
(CFU-S) is lower than that of
normal marrow (Testa and Lajtha,
1973).
We conclude, therefore, that the
answers to the questions which we set out
to investigate are:
(1) That myeloid colony-forming po-
tential at the time of diagnosis or
relapse was not of value in deter-
mining the prognosis in patients
with ALL, either to define those
who would have a short remission
or long survival.
(2) That apart from a lower colony-
forming potential in early remis-
sion, no significant variations from
normal were detectable at several
other stages of the disease.
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